外科理论与实践 ›› 2019, Vol. 24 ›› Issue (01): 15-17.doi: 10.16139/j.1007-9610.2019.01.004
严超, 陆晟, 燕敏, 朱正纲
收稿日期:2018-12-14
出版日期:2019-01-25
发布日期:2019-02-25
通讯作者:
朱正纲,E-mail: zzg1954@hotmail.com
基金资助:
Received:2018-12-14
Online:2019-01-25
Published:2019-02-25
中图分类号:
严超, 陆晟, 燕敏, 朱正纲. 单纯腹腔内游离癌细胞阳性胃癌的诊疗策略[J]. 外科理论与实践, 2019, 24(01): 15-17.
| [1] Li Z, Li Z, Zhang L, et al.Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study[J]. BMC Cancer,2018,18(1):63. [2] Bando E, Yonemura Y, Takeshita Y, et al.Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma[J]. Am J Surg,1999,178(3):256-262. [3] Jamel S, Markar SR, Malietzis G, et al.Prognostic signi-ficance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis[J]. Gastric Cancer,2018,21(1):10-18. [4] Virgilio E, Giarnieri E, Giovagnoli M, et al.Gastric cancer cells in peritoneal lavage fluid: A systematic review comparing cytological with molecular detection for diagnosis of peritoneal metastases and prediction of peritoneal recurrences[J]. Anticancer Res,2018,38(3):1255-1262. [5] Kodera Y, Ito S, Mochizuki Y, et al.Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study[J]. Gastric Cancer,2012,15(3):335-337. [6] Kano K, Aoyama T, Maezawa Y, et al.The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy[J]. Int J Clin Oncol,2017, 22(5):887-896. [7] Kodera Y, Yoshida K, Kochi M, et al.A randomized phase Ⅲ study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage Ⅲ gastric cancer (JACCRO GC-07 trial)[J]. J Clin Oncol,2018,36(15_suppl):4007. [8] Ishigami H, Fujiwara Y, Fukushima R, et al.Phase Ⅲ trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial[J]. J Clin Oncol,2018,36(19):1922-1929. [9] Kuramoto M, Shimada S, Ikeshima S, et al.Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma[J]. Ann Surg,2009,250(2):242-246. [10] Zhu ZG, Tang R, Yan M, et al.Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study[J]. Dig Surg,2006,23(1-2):93-102. [11] Aizawa M, Ishigami H, Yabusaki H, et al.PhaseⅡ study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial[J]. J Clin Oncol,2017,35(4_suppl):96. |
| [1] | 戴志强, 郑金鑫, 唐兆庆, 张启, 顾远, 史忠义, 胡国华, 孙益红. 淋巴结转移率对Ⅱ~Ⅲ期胃癌根治术后病人预后的评估[J]. 外科理论与实践, 2022, 27(05): 429-434. |
| [2] | 李娜娜, 齐涛, 朱黎明. 血清胃蛋白酶原、胃泌素17和幽门螺杆菌IgG抗体在胃部疾病初筛中的临床价值[J]. 诊断学理论与实践, 2022, 21(04): 509-513. |
| [3] | 赵丽琴, 郭伟剑, 余诺亚, 吴珺玮, 张俊. 激活素A对胃癌细胞迁移和有氧糖酵解的影响[J]. 内科理论与实践, 2022, 17(04): 317-323. |
| [4] | 聂明明, 朱正纲. 腹腔镜探查对进展期胃癌精准分期的临床意义[J]. 外科理论与实践, 2022, 27(04): 365-370. |
| [5] | 郭良奇, 严志龙, 张谋成. 腹腔镜经胃腔手术治疗胃黏膜下肿瘤和早期胃癌[J]. 外科理论与实践, 2022, 27(04): 380-383. |
| [6] | 鲍萍萍, 吴春晓, 顾凯, 庞怡, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 吴梦吟, 付晨, 施燕. 上海市2016年胃癌发病特征及2002年至2016年胃癌发病趋势分析[J]. 诊断学理论与实践, 2022, 21(04): 462-469. |
| [7] | 陆伟辉, 刘威, 王聪, 王正林. CXCR2对胃癌细胞侵袭、迁移及凋亡的影响[J]. 外科理论与实践, 2021, 26(5): 430-436. |
| [8] | 朱正纲. 预防与治疗胃癌腹膜转移的若干关键问题[J]. 外科理论与实践, 2021, 26(01): 1-6. |
| [9] | 姬忠贺, 李雁. 肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜转移的现状与前景[J]. 外科理论与实践, 2021, 26(01): 11-16. |
| [10] | 陈小龙, 胡建昆. 腹腔镜探查胃癌腹膜转移的临床意义[J]. 外科理论与实践, 2021, 26(01): 17-20. |
| [11] | 张景辉, 徐袁, 印慨. 胃癌腹膜转移的诊断和相关治疗[J]. 外科理论与实践, 2021, 26(01): 28-33. |
| [12] | 严超, 燕敏, 朱正纲. 新辅助腹腔内联合全身化疗应用于胃癌腹膜转移的临床价值和实施要点[J]. 外科理论与实践, 2021, 26(01): 38-40. |
| [13] | 杨中印, 李琛, 刘文韬, 施敏, 吴珺玮, 郑亚南, 朱正伦, 华子辰, 倪震天, 陆晟, 燕敏, 严超, 朱正纲. 胃癌腹膜转移病人腹腔化疗港并发症发生及危险因素分析[J]. 外科理论与实践, 2021, 26(01): 41-47. |
| [14] | 刘轩宇, 陈磊. 外泌体在胃癌腹膜转移中机制的研究进展[J]. 外科理论与实践, 2021, 26(01): 76-78. |
| [15] | 张斌忠, 董来荣, 何春华, 王胤达. 阿帕替尼联合替吉奥化疗对照SOX方案一线治疗晚期胃癌的临床研究[J]. 外科理论与实践, 2020, 25(04): 341-343. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
